These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1731950)

  • 41. Release of alpha 2-plasmin inhibitor from plasma fibrin clots by activated coagulation factor XIII. Its effect on fibrinolysis.
    Mimuro J; Kimura S; Aoki N
    J Clin Invest; 1986 Mar; 77(3):1006-13. PubMed ID: 2419360
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cross-linking of alpha 2-antiplasmin to fibrin is a key factor in regulating blood clot lysis: species differences.
    van Giezen JJ; Minkema J; Bouma BN; Jansen JW
    Blood Coagul Fibrinolysis; 1993 Dec; 4(6):869-75. PubMed ID: 7511944
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of soluble polymerized fibrin formed in the presence of excess fibrinogen fragment D.
    Knoll D; Hantgan R; Williams J; McDonagh J; Hermans J
    Biochemistry; 1984 Jul; 23(16):3708-15. PubMed ID: 6236846
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An engineered fibrinogen variant AαQ328,366P does not polymerise normally, but retains the ability to form α cross-links.
    Park R; Ping L; Song J; Seo JY; Choi TY; Choi JR; Gorkun OV; Lord ST
    Thromb Haemost; 2013 Feb; 109(2):199-206. PubMed ID: 23224113
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of respective lysine donor and glutamine acceptor sites involved in factor XIIIa-catalyzed fibrin α chain cross-linking.
    Wang W
    J Biol Chem; 2011 Dec; 286(52):44952-64. PubMed ID: 22030394
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of complement-mediated opsonization and phagocytosis of Streptococcus pyogenes by D fragments of fibrinogen and fibrin bound to cell surface M protein.
    Whitnack E; Beachey EH
    J Exp Med; 1985 Dec; 162(6):1983-97. PubMed ID: 3906018
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Calcium modulates plasmin cleavage of the fibrinogen D fragment gamma chain N-terminus: mapping of monoclonal antibody J88B to a plasmin sensitive domain of the gamma chain.
    Odrljin TM; Rybarczyk BJ; Francis CW; Lawrence SO; Hamaguchi M; Simpson-Haidaris PJ
    Biochim Biophys Acta; 1996 Nov; 1298(1):69-77. PubMed ID: 8948490
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of fibrinopeptide cleavage on the plasmic degradation pathways of human cross-linked fibrin.
    Olexa SA; Budzynski AZ
    Biochemistry; 1980 Feb; 19(4):647-51. PubMed ID: 6444516
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Degradation of cross-linked fibrin by matrix metalloproteinase 3 (stromelysin 1): hydrolysis of the gamma Gly 404-Ala 405 peptide bond.
    Bini A; Itoh Y; Kudryk BJ; Nagase H
    Biochemistry; 1996 Oct; 35(40):13056-63. PubMed ID: 8855941
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factor XIIIa incorporates thymosin beta4 preferentially into the fibrin(ogen) alphaC-domains.
    Makogonenko E; Goldstein AL; Bishop PD; Medved L
    Biochemistry; 2004 Aug; 43(33):10748-56. PubMed ID: 15311936
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Binding properties of monoclonal antibodies against human fragment D-dimer of cross-linked fibrin to human plasma clots in an in vivo model in rabbits.
    Holvoet P; Stassen JM; Hashimoto Y; Spriggs D; Devos P; Collen D
    Thromb Haemost; 1989 Apr; 61(2):307-13. PubMed ID: 2749602
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fibroblast migration in fibrin gel matrices.
    Brown LF; Lanir N; McDonagh J; Tognazzi K; Dvorak AM; Dvorak HF
    Am J Pathol; 1993 Jan; 142(1):273-83. PubMed ID: 8424460
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulation of formation of factor XIIIa by its fibrin substrates.
    Lewis SD; Janus TJ; Lorand L; Shafer JA
    Biochemistry; 1985 Nov; 24(24):6772-7. PubMed ID: 2866798
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A monoclonal antibody against a peptide sequence of fibrinogen gamma chain acts as an inhibitor of factor XIII-mediated crosslinking of human fibrin.
    Taubenfeld SM; Song Y; Sheng D; Ball EL; Matsueda GR
    Thromb Haemost; 1995 Sep; 74(3):923-7. PubMed ID: 8571322
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Demonstration of a large molecular weight variant of the gamma chain of normal human plasma fibrinogen.
    Francis CW; Marder VJ; Martin SE
    J Biol Chem; 1980 Jun; 255(12):5599-604. PubMed ID: 6445903
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Release of fibrinopeptides by the slow and fast forms of thrombin.
    Vindigni A; Di Cera E
    Biochemistry; 1996 Apr; 35(14):4417-26. PubMed ID: 8605191
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Localization of segments essential for polymerization and for calcium binding in the gamma-chain of human fibrinogen.
    Váradi A; Scheraga HA
    Biochemistry; 1986 Feb; 25(3):519-28. PubMed ID: 2937452
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reactivity of fibrinogen derivatives with antisera to human fibrin D-dimer and its gamma-gamma chain remnant.
    Cierniewski CS; Janiak A; Nowak P; Augustyniak W
    Thromb Haemost; 1982 Aug; 48(1):33-7. PubMed ID: 7135342
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Functional characterization of fibrinogen Bicêtre II: a gamma 308 Asn-->Lys mutation located near the fibrin D:D interaction sites.
    Marchi RC; Carvajal Z; Boyer-Neumann C; Anglés-Cano E; Weisel JW
    Blood Coagul Fibrinolysis; 2006 Apr; 17(3):193-201. PubMed ID: 16575257
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evidence that catalytically-inactivated thrombin forms non-covalently linked dimers that bridge between fibrin/fibrinogen fibers and enhance fibrin polymerization.
    Mosesson MW; Hernandez I; Siebenlist KR
    Biophys Chem; 2004 Jul; 110(1-2):93-100. PubMed ID: 15223147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.